FDA Pediatric Guidance Designed For "Meaningful" Information, PhRMA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA is implementing FDAMA's pediatric provisions in a "manner designed to yield meaningful labeling information" on the use of drugs in pediatric patients, PhRMA maintains in recent comments on a citizen petition filed by generic drug companies.